Skip to main content
Clinical Trials/NCT04896827
NCT04896827
Suspended
N/A

Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence

Université de Sherbrooke1 site in 1 country244 target enrollmentApril 5, 2022
ConditionsChronic Pain

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Université de Sherbrooke
Enrollment
244
Locations
1
Primary Endpoint
Conditioned pain modulation (CPM) profiles
Status
Suspended
Last Updated
last year

Overview

Brief Summary

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.

Detailed Description

This study aims: 1. To develop and validate a predictive tool (using deep learning and artificial intelligence) to estimate the efficacy of pain control mechanisms. 2. To estimate references values for facial expressions of pain control mechanisms in healthy and in chronic pain participants. The target population will be healthy volunteers and volunteers with chronic pain, male and female, stratified by age. The reference values (healthy volunteers) will be established via a non-parametric method for a standard conditioned pain modulation (CPM) protocol in which two "stimuli tests" of the same intensity and nature (heat) will be applied before and after the application of another "conditioning stimulus" (cold water bath). The perceived pain difference between the 1st and 2nd stimuli tests will reflect the intensity of the DNICs. Participants' facial expressions will be captured simultaneously by three cameras during the CPM testing. These results will be compared to those from volunteers suffering with chronic pain. The clinical decision rule will result from clinical and paraclinical elements correlating with the amplitude of the efficacy of CPM (serum noradrenaline, intensity of pain, heart rate and blood pressure measurements, psychometric questionnaires assessing anxiety, depressive feelings and pain catastrophizing). Logistic regression analysis will determine the best predictors of a CPM deficit.

Registry
clinicaltrials.gov
Start Date
April 5, 2022
End Date
December 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-79 years old
  • No chronic pain
  • Able to provide consent

Exclusion Criteria

  • Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...)
  • Raynaud syndrome
  • Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression)
  • Injuries or loss sensitivity to their forearms or hands
  • Pregnant women or in post-partum period (\<1 year)
  • Participants with chronic pain
  • Inclusion Criteria:
  • 18-79 years old
  • Chronic pain (chronic pain is defined by any regular pain for more than 6 months)
  • Able to provide consent

Outcomes

Primary Outcomes

Conditioned pain modulation (CPM) profiles

Time Frame: Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli)

Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 \[no pain\] to 100 \[most intense pain that could be tolerated\] in healthy and in chronic pain volunteers together.

Temporal summation profiles

Time Frame: Once, at baseline, at recruitment (during the first stimuli test)

Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 \[no pain\] to 100 \[most intense pain that could be tolerated\] in healthy and in chronic pain volunteers together.

Secondary Outcomes

  • Physiologic factors(Once, at baseline, at recruitment)
  • Demographic factors(Once, at baseline, at recruitment)
  • Psychologic factors(Once, at baseline, at recruitment)
  • Conditioned pain modulation (CPM) profiles of healthy volunteers(Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli)
  • Temporal summation profiles of healthy volunteers(Once, at baseline, at recruitment (during the first stimuli test))
  • Conditioned pain modulation (CPM) profiles of volunteers with chronic pain(Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli))
  • Temporal summation profiles of volunteers with chronic pain(Once, at baseline, at recruitment (during the first stimuli test))
  • Facial expressions and postures(Once, at baseline, at recruitment)

Study Sites (1)

Loading locations...

Similar Trials